Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (13068)	8/11/1998 11:18:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

alien, Take a look at a long term chart of your gem CEPH and compare it to Vivus. Hopefully, Vivus is now where CEPH was in the beginning of last week. I think these 2 companies have a lot in common: 1)Both NASDAQ biotech stocks. 2)Both have about 30 million shares outstanding. 3)Both are companies with a limited line of products. 4)Vivus experienced an all time low today--CEPH did last week 5)Both have very similar book values. Now for the differences: 1)Ceph has never turned a profit. 1998 FYE of -$1.70 and 1999 FYE of -.99 2)CEPH is currently trading in the $7.00-8.00 range but was under $5.00 last week. I am sure glad that the CEPH believers did not sell out when they hit an all time low last week and also broke the psycological $5.00/share barrier. In fact the stock's price fired north with a vengance shortly afterwards. In terms of value there is no comparisson. If Ceph is worth $7.00+ currently then Vivus is in no way worth under $7.00/share. Just one vivus long's opinion.